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Abstract. Toxoplasmosis is a disease that infects all warm-blooded animals, including livestocks and 
humans caused by Toxoplasma gondii parasites. There are major drugs used for the therapy, though they have 
some effects to the patients, such as allergy, toxic and teratogenic for fetus. In addition, toxoplasmosis 
treatment is only effective for tachyzoites T. gondii in acute infection, while tissue cysts cannot be eradicated 
in chronic toxoplasmosis Tissue cysts of T. gondii contained in meat that are consumed by humans and meat-
derived products may be important sources of infection for humans. Microneme protein (MIC) is one of 
proteins that belongs to excretory-secretory antigens (ESAs) of Toxoplasma gondii. Microneme 3 protein 
(MIC3) is the protein that plays an important role in the invasion process during cell infection as a mediator 
attachment parasite to the host cell. Recombinant MIC3 protein has been already used for the detection of 
toxoplasmosis and it could induce humoral and cellular immune response in experimental animals. The aim of 
this research was to express MIC3 recombinant protein of T. gondii from local isolate that was cloned into 
expression vector and transformed to E. coli BL21. In the future, recombinant protein MIC3 can be used for 
vaccine candidate and diagnostic tools for toxoplasmosis in animals and humans. Gene of MIC3 T. gondii local 
isolate (1.2 Kbp) was cloned into expression vector pET-32a(+) (5.9 Kbp) and transformed to Escherichia coli 
BL21. Protein from plasmid recombinant (7.1 Kbp) was expressed and performed by culturing recombinant 
bacteria into LB medium containing ampicillin and IPTG. Recombinant protein was isolated by sonication 
method and identified using SDS-PAGE. Finally, the recombinant protein was analyzed by immunoblotting 
using anti-ESAs polyclonal antibody. In conclusion, expression of the MIC3 gene with ~108 kDa has been 
successfully performed by cloning gene encoding for MIC3 protein of T. gondii local isolate that can be 
identified with polyclonal antibody anti-ESAs.  




Toxoplasma gondii is an obligate 
intracellular protozoan parasite that infects all 
warm-blooded animals, including livestocks and 
humans, causing toxoplasmosis (Black and 
Boothroyd, 2000). All mammals and birds that 
are consumed by humans may serve as 
intermediate hosts for T. gondii and thus, may 
be a potential source of infection for humans 
(Tenter, 2009).  
In animals, toxoplasmosis has negative 
impacts in the economics aspect since it can 
cause abortions, still birth and neonatal lost. In 
addition, the tissue cysts T. gondii in meat of 
infected livestock are important source of 
infection for humans. In pregnant woman, 
congenital infection can lead to miscarriage, 
neonates malformation or defect occurring 
during the development of the fetus, such as 
blindness (Gandahusada, 1995; Black and 
Boothroyd, 2000; Tenter et al., 2000; Dubey, 
2007).  
The life cycle of T. gondii includes asexual 
multiplication in various tissues of intermediate 
hosts and sexual reproduction in the intestine 
of definitive hosts. Intermediate hosts are 
probably all warm-blooded animals including 
most livestocks and humans. Definitive hosts 
are members of the family Felidae, for example 
domestic cats. Tissue cysts of T. gondii 




contained in meat and meat-derived products 
may be important sources of infection for 
humans. In livestock, T. gondii tissue cysts are 
most frequently observed in various tissues of 
infected pigs, sheep and goats, and less 
frequently observed in infected poultry, rabbits, 
dogs and horses. By contrast, tissue cysts are 
found only rarely in skeletal muscles of cattle or 
buffaloes (Tenter, 2009). 
There are major drugs used for the therapy 
of toxoplasmosis, such as sulfonamide and 
pyrimethamine which are usually effective for 
therapy. Nevertheless, these drugs have some 
effects to the patients, such as allergy, toxic and 
especially for pregnant women, pyrimethamine 
could cause teratogenic for the fetus. 
Moreover, toxoplasmosis treatment is only 
effective for tachyzoites T. gondii in acute 
infection, while bradyzoites or tissue cysts 
cannot be eradicated in chronic toxoplasmosis 
(Gandahusada, 1995; Carruthers, 2004). 
Therefore, the studies about prevention and 
treatment of toxoplasmosis are important to 
conduct. 
In molecular terms, invasion of host cells by 
T. gondii is closely coupled by the release of 
proteins stored within apical secretory granule 
knows as micronemes, which play a central role 
in the recognition of and adhesion to the hosts 
cells, rhoptries and dense granules (Ismael et 
al., 2003; Beghetto et al., 2005; Buffolano et al., 
2005). Among these proteins, the MIC3 protein 
contains adhesive motifs and has been shown 
to bind to the surface of the host cells. There 
are Lectin-like domain required for binding and 
Epidermal Growth Factor-like (EGF-like) domain 
containing human B and T cell epitopes (Garcia- 
Réquet et al., 2000; Cérède et al., 2002;  
Beghetto et al., 2005).  
Several previous studies have demonstrated 
the usefulness of recombinant antigens for 
serological diagnosis of T. gondii, such as SAG 
(surface antigen) (Beghetto et al., 2005; 
Buffolano et al., 2005), GRA (Igarashi et al., 
2008; Wihadmadyatami, 2009), ROP (Ahn et al., 
2006; Igarashi et al., 2008) and MIC (Ismael et 
al., 2003; Beghetto et al., 2005; Buffolano et al., 
2005). The use of recombinant antigens would 
allow better standardization of the tests; 
reduce production costs, reproducible, safer 
and efficient to produce recombinant protein in 
adequate amount (Hiszczyoska-Sawicka, 2005). 
The result study of MIC3 (Ismael et al., 2003; 
2009) shows that cloning and expression a 
recombinant plasmid DNA encoding the MIC3 
of T. gondii RH isolate induced a strong specific 
humoral and cellular immune responses. This 
study was the first demonstration showing that 
the MIC3 of T. gondii is a potent and effective 
vaccine candidate against toxoplasmosis.  
The study was aimed to express  
recombinant MIC3 gene encoding MIC3 protein 
that has been successfully cloned into E. coli 
(Indrasanti et al, 2011) to produce MIC3 
recombinant protein. It can be used as vaccine 
candidate and toxoplasmosis diagnostic tool for 
animals especially livestocks, and humans. 
Materials and Methods 
Toxoplasma gondii tachyzoites DNA and 
Female Balb/C mice, 6 to 8 weeks old, were 
obtained from Study Program of Biotechnology, 
University of Gadjah Mada, Yogyakarta. 
Recombinant bacterial colonies XL-1 Blue 
brought recombinant plasmid pGEM-T with 
insert MIC3 (pWTA-M3), and primer specific for 
MIC3 M3F1 (has HindIII restriction site) and 
M3R1 (has EcoRV restriction site) for positive 
controls (Dewi, 2006). Protein of recombinant 
MIC3s was recombinant protein from cloning 
MIC3 gene amplified using M3F1 and M3R1 
primers into expression vector and 
transformated to E. coli BL21 as negative 
control for immunoblotting. 
Isolation and cloning of MIC3 gene 
Toxoplasma gondii tachyzoites DNA were 
amplified by Polymerase Chain Reaction (PCR) 
to amplify only the sequence coding for the 
part of MIC3 gene with EcoRV and HindIII 




restriction sites at 5’ end of forward and 
reverse primers (Invitrogene), respectively. 
Forward primer (M3F3): 
5’GTGTGATATCCTTGTCCAACACTGGGTA3’ and 
reverse primer (M3R3): 
5’CACGAAGCTTTGCGAATGGGCG3’. Polymerase 
Chain Reaction product was purified by EZ-10 
spin coloumn purification kit (Bio Basic Inc.), cut 
with endonuclease restriction enzyme EcoRV 
and HindIII and ligated into expression vector 
pET-32a(+) (Novagen). Recombinant plasmid 
pET-32a(+)-MIC3a was transformed into 
competent E. coli strain BL21 (Invitrogen).  
Gene expression 
Escherichia coli strain BL21 transformed with 
recombinant plasmid was grown in Luria 
Bertani (LB) medium supplemented with 25 µl/ 
ml ampicillin (Boehringer Mannheim) at 37 oC 
overnight. Five flasks containing 25 ml of LB 
containing 25 µl/ ml ampicillin were inoculated 
by 2.5 ml samples of the overnight cultures. The 
cultures were grown at 37 oC wih vigorous 
shaking until the OD600 ~0,5-1. The cultures 
were induced by 1 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) for 1, 2, 3, 4 hr at 
37 oC. Induced cell and control cell were 
pelleted by centrifuge 3000 rpm for 20 minutes 
at 4 °C. The pellet was washed in 25 ml of 
phosphate buffered saline (PBS) I pH 7 (145 mM 
NaCl, 10 mM Na2HPO4, 10 mM NaH2PO4 and 
ddH2O up to 1 L) three times and resuspended 
in 250 µl PBS I. The cell pellet was sonicated six 
times on ice in pulses of 30 seconds and 
centrifuged at 12.000 rpm for 10 minutes. Right 
molecular weight of the recombinant protein 
was confirmed by sodium dodecyl sulphate-
polyacrilamide gel electrophoresis (SDS-PAGE) 
in comparison with protein marker. 
Enzyme Linked Immunosorbent Assay (ELISA) 
Levels of polyclonal antibody in serum samples 
were determined by standards procedures. 
Briefly, the 96 flat-bottom wells of microtiter 
plate (Nunc Gene) was coated overnight at 37°C 
with 5 µg/ml ESA protein in 100 µl buffer 
coating (0,2 M Na2CO3, 0,2 M NaHCO3). The 
plate was washed with washing solution (0,15 
M NaCl, 0.05% Triton X-100, 0.02% NaN3); 
nonspecific binding sites were blocked with 
blocking buffer (1% BSA + 0,02% NaN3 in PBS I) 
for 1 h at 37°C. After the plate was washed with 
washing solution, it was coated with 100µl mice 
serum (polyclonal antibody anti-ESA) with 
graduate dilution 1:50, 1:100, 1:200, 1:400, 
1:800, 1:1600, 1:3200, 1:6400 and incubated 
for 1 h at 37oC. After the plate was washed, 
bound antibodies were detected by incubation 
for 1 h at 37°C with a goat anti-mouse IgG–
alkaline phosphatase conjugate (Sigma) diluted 
1:3000 in incubation buffer. After the plates 
were washed, the bound phosphatase activity 
was measured with p-nitrophenylphosphate at 
1 mg/ml. The reaction was stopped after 
incubating for 15 min at 37°C; the OD405 of 
sample was then read in ELISA reader.  
Western-blot analysis 
The samples were prepared for SDS-PAGE by 
adding 12.5  µl 5x sample buffer to 50 µl of the 
samples. They were boiled for 2 minutes and 
loaded into 12% polyacrilamide gel. The 
proteins were transferred to nitrocellulose 
membrane at 500 mA for ±1-2 hr and probed 
using anti-ESA polyclonal antibody diluted 
1:100 in incubation buffer pH 7,2 (0,1 M NaCl, 
50 mM NaHPO4, 50 mM Na2HPO4, 1% BSA, 
0,05% Triton X-100, 0,02% NaN3, and ddH2O up 
to 1 L). The bound antibodies were detected 
using anti-mouse immunoglobulin G (IgG)-
alkaline phosphatase conjugate (Sigma) diluted 
1:3000 in incubation buffer. Alkaline 
phosphatase activity was detected using 5-
bromo-4-chloro-3-indolyl phosphate/ nitroblue 
tetrazolium (BCIP/NBT) liquid substrate system 
(Sigma). Standard molecular masses (prestained 
SDS-PAGE standards, Sigma markerTM Wide 
Range) were used. 




Results and Discussion 
Gene MIC3 cloning of T. gondii into E. coli 
has been successfully done (Indrasanti et al., 
2011). In the last research, forward and reverse 
primers were designed with EcoRV and HindIII 
restriction site, respectively. Restriction sites 
were used to ligate insert MIC3 and expression 
vector pET-32a(+). Recombinant plasmid pET-
32a(+)-MIC3 called as pET-M3 was transformed 
into competent E. coli strain BL21 using heat 
shock method. The aim of this research was to 
express recombinant MIC3 gene of T. gondii in 
E. coli. The result of this research was 
recombinant protein MIC3 that can be used for 
vaccine candidate and diagnostic tools for 
Toxoplasmosis in the future. 
The previous study about cloned gene from 
secretory organelles is gained from T. gondii, 
micronemes. The entire MIC3 open reading 
frame was amplified from tachyzoites DNA of T. 
gondii local isolate by Polymerase Chain 
Reaction (PCR) by Ismael et al. (2003) and Dewi 
(2006). They  have successfully amplified MIC3 
gene using these primers and obtained 
amplicon 1155 bp and 4200 bp, respectively.  
Amplicon of 2247 bp was sequenced, 
including the complete cDNA sequence and 
additional flanking sequences by Garcia- Réquet 
et al. (2000) (GenBank Accession No. 
AJ132530). This showed that the MIC3 gene 
contained no intron. The genomic sequence 
matched perfectly to the cDNA. There were no 
typical eukaryotic TATA or CCAAT consensus 
promoter sequences in the 5’ non-coding 
region. Forward and reverse primers were 
attached from bases 666-692 and 1812-1833, 
respectively. Coding region between both 
primers was amplified MIC3 gene as long as 
1170 bp (bases 666-1833) (Garcia- Réquet et 
al., 2000).  
Excretory secretory antigens which derives 
from tachyzoites T. gondii, is used as antigen to 
stimulate polyclonal antibody on female mice 
Balb/C. Levels of polyclonal antibody in serum 
samples were determined by ELISA for 
immunoblotting as 2,894 (diluted 1:100). 
Expression of recombinant MIC3 protein has 
been done by culturing isolate at 37 oC with 
vigorous shaking until the OD600 ~0,5-1 for 
protein isolation. The cultures were induced by 
1 mM isopropyl-β-D-thiogalactopyranoside 
(IPTG) for 1, 2, 3, 4 hr at 37oC. Measurement of 
protein concentration showed at 3 h and 4 h, 
was 8,79 µg/ µl and 10,34 µg/ µl, respectively. 
The result of recombinant microneme protein 
purification with IPTG induction for 3 hours on 
37oC has been done by Beghetto (2005) and it 
has been successfully recognized by T cell and 
toxoplasmosis patient antibody using ELISA.  
Expression of recombinant protein on SDS-
PAGE showed more thickness band of protein 
on molecular mass approximately ~90 kDa. The 
thicknesses of band protein were showed in 
accordance time of gradually IPTG induction 
(Line 3, 4, 5, 6, 7). The BL21 E. coli transformed 
with pET-M3 expressed a dimeric recombinant 
MIC3 protein that was secreted into the 
supernatant as well as being present in the cell 
pellets. It had an apparent molecular mass 
(~108 kDa) which was ~18 kDa greater than 
that of the native MIC3 protein (90 kDa) 
(Garcia- Réquet et al., 2000; Cérède et al., 
2005). This finding could be explained by fusion 
proteins of Trx•Tag (109 aa), His•Tag (6-10 aa), 
and S•Tag (15 aa) from expression vector pET-
32a(+) (Novagen, 2001; Igarashi et al., 2008). 
These results are consistent with those of 
Ismael et al. (2003) and Cérède et al. (2002), 
which demonstrated that the increase in size of 
the recombinant protein was due to failure to 
cleave the MIC3 propeptide in BHK-21 cells; this 
was confirmed by probing the immunoblot with 
a specific anti-propeptida serum. These authors 
also showed that the presence of the 
propeptide inhibited the adhesive function of 
the MIC3 protein but that it remained 
antigenic, because it was well-recognized by 
serum from a T. gondii-infected mouse. To 
confirm    the    detection   of   specific   anti-ESA  
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Figure 1. SDS-PAGE electrophoresis of MIC3 recombinant proteins. M, molecular mass marker (Sigma), lane 1, 
BL21 E.coli protein, lane 2, MIC3s protein, lane 3, MIC3 protein after 1 mM IPTG induction for 4 h, lane 4, MIC3 
protein after 1 mM IPTG induction for 3 h, lane 5, MIC3 protein after 1 mM IPTG induction for 2 h, lane 6, MIC3 
protein after 1 mM IPTG induction for 1 h, lane 7, MIC3 protein without 1 mM IPTG induction. Arrow shows 
band of recombinant protein. 
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Figure 2. Western blotting using polyclonal antibody anti-ESA. Panel A: Blotting MIC3 recombinant protein 
prestained with amido black, M, molecular mass marker (Sigma), line 1, MIC3 recombinant protein, line 2, 
MIC3s recombinant protein. Panel B: Immunoblotting, line 1, MIC3 recombinant protein induced with IPTG for 
4 h, line 2, MIC3 recombinant protein induced with IPTG for 3 h, line 3, protein MIC3s induced with IPTG for 4 



















































antibody by recombinant MIC-3 antigen, the 
Western blot was carried out.  
Figure 2, Panel B shows band indicating 
positive reaction between polyclonal antibody 
anti ESA and recombinant protein pET-M3 (Line 
1 and 2) whereas on recombinant protein pET-
M3s, the band is not formed (negative) (Line 3). 
The cross reactivity observed in the Western 
blotting result using polyclonal antibody against 
recombinant protein can be explained by the 
study using crude recombinant protein and 
polyclonal antibody, not the purified ones. The 
occurrence of cross-reaction should be avoided 
due to the mistake in analysis. Further study 
needs to be conducted on DNA sequence 
identification or amino acid sequence 
identification on recombinant protein. 
Recombinant protein purification and 
monoclonal antibody should be used in order to 
get more specific result.  
Conclusion 
The result of the study showed that 
expression of the MIC3 gene has been 
successfully performed with molecular weight 
~108 kDa.  
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